F. Ueland

1.8k total citations
24 papers, 1.2k citations indexed

About

F. Ueland is a scholar working on Reproductive Medicine, Surgery and Obstetrics and Gynecology. According to data from OpenAlex, F. Ueland has authored 24 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Reproductive Medicine, 5 papers in Surgery and 5 papers in Obstetrics and Gynecology. Recurrent topics in F. Ueland's work include Ovarian cancer diagnosis and treatment (19 papers), Endometriosis Research and Treatment (6 papers) and Endometrial and Cervical Cancer Treatments (5 papers). F. Ueland is often cited by papers focused on Ovarian cancer diagnosis and treatment (19 papers), Endometriosis Research and Treatment (6 papers) and Endometrial and Cervical Cancer Treatments (5 papers). F. Ueland collaborates with scholars based in United States, Netherlands and Denmark. F. Ueland's co-authors include John R. van Nagell, Richard J. Kryscio, Paul D. DePriest, Edward J. Pavlik, Holly H. Gallion, Mark B. Reedy, Christopher P. DeSimone, S. Goodrich, Lauren Baldwin and Leigh G. Seamon and has published in prestigious journals such as Journal of Clinical Oncology, Obstetrics and Gynecology and Gynecologic Oncology.

In The Last Decade

F. Ueland

21 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Ueland United States 13 937 389 269 202 187 24 1.2k
Arto Leminen Finland 23 628 0.7× 270 0.7× 304 1.1× 348 1.7× 249 1.3× 38 1.2k
Aasia Saleemuddin United States 10 885 0.9× 564 1.4× 115 0.4× 211 1.0× 184 1.0× 10 1.3k
APM Heintz Netherlands 5 861 0.9× 446 1.1× 392 1.5× 206 1.0× 216 1.2× 6 1.2k
Lotte Nedergaard Denmark 21 916 1.0× 681 1.8× 343 1.3× 200 1.0× 220 1.2× 41 1.4k
Frédéric Buxant Belgium 16 486 0.5× 326 0.8× 142 0.5× 175 0.9× 264 1.4× 49 1.1k
Jurgen M.J. Piek Netherlands 18 1.1k 1.2× 527 1.4× 188 0.7× 286 1.4× 269 1.4× 93 1.6k
Chad A. Hamilton United States 24 657 0.7× 556 1.4× 353 1.3× 335 1.7× 300 1.6× 67 1.4k
Joan Murphy Canada 16 446 0.5× 274 0.7× 127 0.5× 281 1.4× 162 0.9× 22 910
S. Pecorelli Italy 4 895 1.0× 460 1.2× 456 1.7× 224 1.1× 284 1.5× 4 1.2k
Zainab Basir United States 17 834 0.9× 614 1.6× 96 0.4× 354 1.8× 134 0.7× 28 1.4k

Countries citing papers authored by F. Ueland

Since Specialization
Citations

This map shows the geographic impact of F. Ueland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Ueland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Ueland more than expected).

Fields of papers citing papers by F. Ueland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Ueland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Ueland. The network helps show where F. Ueland may publish in the future.

Co-authorship network of co-authors of F. Ueland

This figure shows the co-authorship network connecting the top 25 collaborators of F. Ueland. A scholar is included among the top collaborators of F. Ueland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Ueland. F. Ueland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Bingwei, Dava West, Lauren Baldwin, et al.. (2017). Inhibition of the integrin/FAK signaling axis and c-Myc synergistically disrupts ovarian cancer malignancy. Oncogenesis. 6(1). e295–e295. 62 indexed citations
2.
Baldwin, Lauren, et al.. (2016). Frequency of intimate partner violence history in gynecologic and breast cancers. Gynecologic Oncology. 141. 124–124.
3.
Santoso, Joseph T., et al.. (2013). Computed tomography adnexal mass score to estimate risk for ovarian cancer. Archives of Gynecology and Obstetrics. 289(3). 595–600. 5 indexed citations
4.
Baldwin, Lauren, Bin Huang, Rachel W. Miller, et al.. (2012). Ten-Year Relative Survival for Epithelial Ovarian Cancer. Obstetrics and Gynecology. 120(3). 612–618. 263 indexed citations
5.
Baldwin, Lauren, Rachel Ware, Binhao Huang, et al.. (2011). Ten-year relative survival for epithelial ovarian cancer. Gynecologic Oncology. 120. S34–S35. 16 indexed citations
6.
Podzielinski, Iwona, Rachel Ware, S. Goodrich, et al.. (2010). Risk of malignancy in sonographically confirmed septated cystic ovarian tumors. Gynecologic Oncology. 118(3). 278–282. 32 indexed citations
7.
McDonald, John, Stacey L. Doran, Christopher P. DeSimone, et al.. (2010). Predicting Risk of Malignancy in Adnexal Masses. Obstetrics and Gynecology. 115(4). 687–694. 54 indexed citations
8.
Ware, Rachel, Laura–Mae Baldwin, Bin Huang, et al.. (2010). Relative conditional survival in 41,476 patients with ovarian cancer.. Journal of Clinical Oncology. 28(15_suppl). 5090–5090. 1 indexed citations
9.
10.
Disis, ML, Saul E. Rivkin, Andre T. Baron, et al.. (2006). Progress in ovarian cancer research: Proceedings of the 5th Biennial Ovarian Cancer Research Symposium. International Journal of Gynecological Cancer. 16(2). 463–469. 2 indexed citations
11.
Disis, ML, Saul E. Rivkin, Andre T. Baron, et al.. (2006). Progress in ovarian cancer research: Proceedings of the 5th Biennial Ovarian Cancer Research Symposium. International Journal of Gynecological Cancer. 16(2). 463–469. 1 indexed citations
12.
Ueland, F., Annette Bicher, Don S. Dizon, et al.. (2006). A randomized phase II trial with gemcitabine with or without pertuzumab (rhuMAb 2C4) in platinum-resistant ovarian cancer (OC): Preliminary safety data. Journal of Clinical Oncology. 24(18_suppl). 13001–13001. 3 indexed citations
13.
Bast, Robert C., Ignace Vergote, Claus Høgdall, et al.. (2006). A large-scale multi-center independent validation study of a panel of seven biomarkers for the detection of ovarian cancer. Journal of Clinical Oncology. 24(18_suppl). 5057–5057. 4 indexed citations
14.
Ueland, F., Paul D. DePriest, Christopher P. DeSimone, et al.. (2005). The accuracy of examination under anesthesia and transvaginal sonography in evaluating ovarian size. Gynecologic Oncology. 99(2). 400–403. 36 indexed citations
15.
Ueland, F., Paul D. DePriest, Edward J. Pavlik, Richard J. Kryscio, & John R. van Nagell. (2003). Preoperative differentiation of malignant from benign ovarian tumors: the efficacy of morphology indexing and Doppler flow sonography. Gynecologic Oncology. 91(1). 46–50. 124 indexed citations
16.
Nagell, John R. van, Paul D. DePriest, Mark B. Reedy, et al.. (2000). The Efficacy of Transvaginal Sonographic Screening in Asymptomatic Women at Risk for Ovarian Cancer. Gynecologic Oncology. 77(3). 350–356. 237 indexed citations
17.
Pavlik, Edward J., Paul D. DePriest, Holly H. Gallion, et al.. (2000). Ovarian Volume Related to Age. Gynecologic Oncology. 77(3). 410–412. 195 indexed citations
18.
Nagell, John R. van & F. Ueland. (1999). Ultrasound evaluation of pelvic masses: predictors of malignancy for the general gynecologist. Current Opinion in Obstetrics & Gynecology. 11(1). 45–49. 16 indexed citations
19.
Reedy, Mark B., et al.. (1999). Ovarian Steroid Cell Tumors, Not Otherwise Specified: A Case Report and Literature Review. Gynecologic Oncology. 75(2). 293–297. 38 indexed citations
20.
Bailey, Candice L., F. Ueland, Paul D. DePriest, et al.. (1998). The Malignant Potential of Small Cystic Ovarian Tumors in Women over 50 Years of Age. Gynecologic Oncology. 69(1). 3–7. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arto Leminen Breakdown of academic impact, for papers by Aasia Saleemuddin Breakdown of academic impact, for papers by APM Heintz Breakdown of academic impact, for papers by Lotte Nedergaard Breakdown of academic impact, for papers by Frédéric Buxant Breakdown of academic impact, for papers by Jurgen M.J. Piek Breakdown of academic impact, for papers by Chad A. Hamilton Breakdown of academic impact, for papers by Joan Murphy Breakdown of academic impact, for papers by S. Pecorelli Breakdown of academic impact, for papers by Zainab Basir
Rankless by CCL
2026